(Q47664453)

4 February 2018

title

Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model (English)

1 reference

4 February 2018

main subject

Bordetella parapertussis

object named as

Bordetella parapertussis

1 reference

3

Frits R Mooi

1 reference

4 February 2018

author name string

Silke David

series ordinal

1

1 reference

4 February 2018

Ralph van Furth

series ordinal

2

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

22

1 reference

4 February 2018

issue

15-16

1 reference

4 February 2018

page(s)

1892-1898

1 reference

4 February 2018

Update on respiratory infection caused by Bordetella parapertussis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Genetic diversity and relationships in populations of Bordetella spp.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Epidemics of parapertussis. 20 years' observations in Denmark.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Parapertussis infection followed by pertussis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Association of Bordetella pertussis with host immune cells in the mouse lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Disquisitions of Original Antigenic Sin. I. Evidence in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

A causal relationship between Bordetella pertussis and Bordetella parapertussis infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

A simplified liquid culture medium for the growth of Hemophilus pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.11.005

1 reference

4 February 2018

1 reference

4 February 2018